Miriam specializes in matters involving intellectual property, licensing, privacy law and commercial law.

Miriam has represented companies in the biotechnology, medical device and pharmaceutical industries. In addition, she represents clients in matters involving the Israeli Innovation Authority.

Miriam has valuable experience in matters related to the IIA in all the stages of a company’s life cycle. She has submitted complex applications to the IIA and has provided advice and analyses to various clients in connection with IIA rules and restrictions.

Miriam also counsels clients, whether start-up or large global corporations, on a wide range of privacy matters, including in connection with processing personal data, marketing, data security, data breach and cross-border transfers.
Miriam also addresses privacy matters arising in the context of commercial transactions.


  • Represented Intel Inc. in numerous acquisitions in Israel, including the acquisitions of Mobileye for $15.3 billion (the largest tech acquisition ever performed in Israel), Tower Semiconductor for $5.4 billion Habana Labs for $2 billion, and Granulate.
  • Represented NVIDIA in the acquisition of Mellanox Technologies for $7 billion (2nd largest tech transaction in Israel history).
  • Represented Palo Alto Networks in their recent acquisitions in Israel, including: Puresec for $500 million, Twistlock for $450 million, Cider Security for $300 million, Bridgecrew for $200 million, and Crusoe Security.


Intellectual Property: Commercial/Transactions, Healthcare and Life Sciences
Legal500 Next Generation Partner
Next Generation Partner - Intellectual Property: Commercial/Transactions, Healthcare and Life Sciences
2011 The Hebrew University of Jerusalem | LLB (with honors)
2006 The Hebrew University of Jerusalem | PhD in history
2013 Israel
Miriam Friedmann

Miriam Friedmann

31 Hillel Street, Jerusalem
Miriam Friedmann